PRINCIPAL FINANCIAL GROUP INC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$718,920
-1.1%
7,051
-11.8%
0.00%
-100.0%
Q1 2023$726,633
+133.3%
7,992
-2.5%
0.00%
Q4 2022$311,480
+39.1%
8,199
+11.2%
0.00%
Q2 2022$224,000
-80.9%
7,371
-36.6%
0.00%
-100.0%
Q3 2021$1,170,000
-27.5%
11,622
+1.9%
0.00%0.0%
Q2 2021$1,613,000
+79.4%
11,401
+26.5%
0.00%0.0%
Q1 2021$899,000
-16.4%
9,015
+3.5%
0.00%0.0%
Q4 2020$1,076,000
+26.7%
8,709
-0.1%
0.00%0.0%
Q3 2020$849,000
-60.9%
8,714
-37.5%
0.00%
-50.0%
Q2 2020$2,174,000
+42.5%
13,935
+31.8%
0.00%0.0%
Q1 2020$1,526,000
-16.1%
10,575
+18.8%
0.00%0.0%
Q4 2019$1,819,000
+169.1%
8,900
+5.7%
0.00%
+100.0%
Q3 2019$676,000
-13.2%
8,424
+2.0%
0.00%0.0%
Q2 2019$779,000
+24.4%
8,256
+12.8%
0.00%0.0%
Q1 2019$626,000
+149.4%
7,319
+138.5%
0.00%
Q3 2018$251,0003,0690.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$288,821,00055.24%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 100,000$9,970,00015.20%
Tolleson Wealth Management, Inc. 108,000$10,768,0003.25%
MADDEN SECURITIES Corp 34,787$3,468,0002.03%
Biondo Investment Advisors, LLC 101,204$10,090,0002.01%
LBJ Family Wealth Advisors, Ltd. 30,368$3,027,0001.91%
Duquesne Family Office 749,897$74,765,0001.65%
Sofinnova Investments, Inc. 238,520$23,780,0001.43%
Camber Capital Management LP 400,000$39,880,0001.37%
Integral Health Asset Management, LLC 44,000$4,387,0001.25%
View complete list of REATA PHARMACEUTICALS INC shareholders